In conclusion, the results from our present study demonstrated that CD38 deficiency prevented HFD-induced NAFLD, and the underlying mechanisms were mainly related to activating Sirtuins/PPARα/SOD2 signaling pathway. This evidence concerns the gene SOD2 and metabolic dysfunction-associated steatotic liver disease.